[Form 4] Hillenbrand, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Tamara Morytko, Sr. VP & President, MTS of Hillenbrand, Inc. (HI), reported changes in her holdings on a Form 4 covering transactions dated 09/30/2025 and 10/01/2025. The filing shows a disposition of 5,671 shares of common stock (Table I, Code V). It also records the settlement/conversion of multiple Restricted Stock Unit grants into common shares: 70, 39, 92, and 10 shares reported on 09/30/2025, and a 2,248-share settlement on 10/01/2025. Each RSU is shown with a $0 price reflecting settlement in shares, and the filing lists the post-transaction beneficial ownership totals for each grant line.

Positive

• 70 Restricted Stock Units from the 09/11/2023 award converted to 70 common shares (post-transaction total 8,568)
• 39 Restricted Stock Units from the 12/7/2023 award converted to 39 common shares (post-transaction total 4,748)
• 92 Restricted Stock Units from the 12/5/2024 award converted to 92 common shares (post-transaction total 11,203)
• 10 Matching RSUs (granted 03/31/2025) converted to 10 common shares (post-transaction total 1,235)
• 2,248 Matching RSUs (granted 10/1/2025) recorded as acquired and shown as 2,248 common shares (post-transaction total 2,248)

Negative

• 5,671 shares of common stock were disposed (Table I, Code V)
• Multiple RSU settlements indicate share increases that may dilute outstanding shares if settled in stock (total new shares across lines: 2,459 on 09/30/2025 plus 2,248 on 10/01/2025)

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Morytko Tamara

(Last) (First) (Middle)

ONE BATESVILLE BOULEVARD

(Street)

BATESVILLE IN 47006

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hillenbrand, Inc. [ HI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Sr. VP & President, MTS

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								5,671	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units (Deferred Stock Award 09/11/2023)	(1)	09/30/2025		A(2)		70		(3)	(3)	Common Stock	70	$0	8,568	D
Restricted Stock Units (Deferred Stock Award 12/7/2023)	(1)	09/30/2025		A(2)		39		(4)	(4)	Common Stock	39	$0	4,748	D
Restricted Stock Units (Deferred Stock Award 12/5/2024)	(1)	09/30/2025		A(2)		92		(5)	(5)	Common Stock	92	$0	11,203	D
Restricted Stock Units (Matching RSU Framework 03/31/2025)	(1)	09/30/2025		A(2)		10		(6)	(6)	Common Stock	10	$0	1,235	D
Restricted Stock Units (Matching RSU Framework 10/1/2025)	(1)	10/01/2025		A(2)		2,248		(7)	(7)	Common Stock	2,248	$0	2,248	D

Explanation of Responses:

1. Each Restricted Stock Unit represents the contingent right to receive one share of the issuer's common stock.

2. Restricted Stock Units are entitled to dividend equivalent rights which accrue on dividend record dates.

3. Restricted Stock Units scheduled to vest one-quarter on 9/11/2024, one-quarter on 9/11/2025, and one-half on 9/11/2026.

4. Restricted Stock Units scheduled to vest one-third on 12/7/2024, one-third on 12/7/2025, and one-third on 12/7/2026.

5. Restricted Stock Units scheduled to vest one-third on 12/5/2025, one-third on 12/5/2026, and one-third on 12/5/2027.

6. Represents Matching RSUs granted under the Company's Executive Share Match framework that will vest on March 31, 2028, and be settled in shares of the Company's common stock or cash to the extent the vesting conditions of the framework are satisfied.

7. Represents Matching RSUs granted under the Company's Executive Share Match framework that will vest on October 1, 2028, and be settled in shares of the Company's common stock or cash to the extent the vesting conditions of the framework are satisfied.

Remarks:

	/s/ Allison A. Westfall, Attorney-in-Fact for Tamara Morytko	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Tamara Morytko report on Hillenbrand (HI) Form 4?

The Form 4 reports a disposition of 5,671 common shares and the acquisition/settlement of Restricted Stock Units totaling 70, 39, 92, 10 shares on 09/30/2025 and 2,248 shares on 10/01/2025.

Were any option exercises or purchases reported by the insider?

No option exercises or cash purchases are shown; the securities acquired are listed as Restricted Stock Units settled into common shares at a $0 price.

What is the reporting person’s role at Hillenbrand and how filed was the Form 4?

The reporting person is listed as Sr. VP & President, MTS. The Form 4 was filed as an individual filing for one reporting person.

Do the RSUs carry dividend rights or scheduled vesting?

Yes. The filing states each RSU carries dividend equivalent rights and includes vesting schedules for each award (e.g., quarterly or annual vesting schedules shown in the explanations).

What are the post-transaction beneficial ownership totals shown?

The filing lists post-transaction beneficial ownership for each line: 8,568, 4,748, 11,203, 1,235, and 2,248 shares respectively.